OS in patients with multiple myeloma treated with auto/RIC allo or auto alone. OS was better in the auto/RICallo group long term: 49% vs 36% at 96 months in the auto/RICallo and auto groups, respectively (P = .030). All patients included—ITT. Gray = auto/RICallo; black = auto.